Posted by Michael Wonder on 19 Jun 2022
Drug pricing debate in Washington is a headache for pharma
17 June 2022 - Last-ditch effort by Democrats to pass slimmed-down version of Build Back Better could include measures on drug pricing.
Big Pharma loves political gridlock. In fact, shares of pharmaceutical and biotechnology companies tend to outperform the broader market when Congress is divided.
